SCHEMBL22242701

SCHEMBL22242701

N[C@H]1C[C@H](CO)[C@H](N)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26085597 0.88 — —
SCHEMBL855477 0.88 — —
SCHEMBL10232278 0.88 — —
SCHEMBL855476 0.88 — —
SCHEMBL28230079 0.88 — —
SCHEMBL19662328 0.88 — —
Hydrochloric Acid SCHEMBL20983270 0.85 — —
Hydrochloric Acid SCHEMBL20983360 0.85 — —
Hydrochloric Acid SCHEMBL2730680 0.85 — —
SCHEMBL24286407 0.76 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020150473-A2 PCSK9 INHIBITORS AND METHODS OF USE THEREOF DOGMA THERAPEUTICS, INC. (US) 2020-07-23 — — WO disclosed
Send feedback